Skip to content
Dx

ICD-10-CM 2027 diagnosis code

D72.111Lymphocytic Variant Hypereosinophilic Syndrome [LHES]

✓ Billable / specific

D72.111 is a valid, billable ICD-10-CM code for lymphocytic variant hypereosinophilic syndrome [lhes]. It can be reported on claims for dates of service from October 1, 2026 – September 30, 2027.

Code last changed in FY2021 (effective October 1, 2020). Source: official FY2027 ICD-10-CM release from CDC/NCHS and CMS. Page updated September 29, 2026. About our data

About D72.111

D72.111 is the ICD-10-CM diagnosis code for lymphocytic Variant Hypereosinophilic Syndrome [LHES]. It belongs to category D72 (other disorders of white blood cells), block D70-D77 (other disorders of blood and blood-forming organs) and chapter 3 (diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism). It is billable, so it can be reported on its own for dates of service from October 1, 2026 through September 30, 2027.

Within D72.11 (hypereosinophilic syndrome [HES]), D72.111 is specifically for lymphocytic Variant Hypereosinophilic Syndrome [LHES]. Related codes cover idiopathic hypereosinophilic syndrome [IHES] (D72.110), other hypereosinophilic syndrome (D72.118) and unspecified (D72.119).

It is not a CC or MCC, so as a secondary diagnosis it doesn't change the MS-DRG severity level.

In MS-DRG v44.0, it is part of the grouping logic for DRG 814 (Reticuloendothelial and Immunity Disorders with MCC, relative weight 2.0729), DRG 815 (Reticuloendothelial and Immunity Disorders with CC, relative weight 1.0444) and DRG 816 (Reticuloendothelial and Immunity Disorders without CC/MCC, relative weight 0.7381), in MDC 16 (Diseases and Disorders of the Blood and Blood Forming Organs and Immunological Disorders), as a principal or secondary diagnosis. The DRG a claim lands in depends on the principal diagnosis, procedures and any CC/MCC secondary diagnoses.

It was added in FY2021, effective October 1, 2020.

Coding notes

Applicable toConditions and synonyms classified to this code
  • Lymphocyte variant hypereosinophilia
Code alsoTwo codes may be needed; sequencing depends on circumstances
  • , if applicable, any associated lymphocytic neoplastic disorder

Notes that apply from higher levels

Instructions written at a parent level also apply to D72.111.

› From D72.1 Eosinophilia
Excludes2
  • Löffler's syndrome (J82.89)
  • pulmonary eosinophilia (J82.-)
› From D72 Other disorders of white blood cells
Excludes1
Excludes2
  • neutropenia (D70)

Broader instructions also apply from Chapter 3: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism.

Alphabetic index entries

1 entries

Terms in the official ICD-10-CM index that lead to D72.111.

MS-DRG v44.0 grouping

All DRGs →

Inpatient MS-DRGs this diagnosis can group to, as the principal or a secondary diagnosis, depending on the rest of the claim.

Code history

  1. 2016
  2. 2017
  3. 2018
  4. 2019
  5. 2020
  6. 2021
  7. 2022
  8. 2023
  9. 2024
  10. 2025
  11. 2026
  12. 2027
  • FY2021 (effective 10/1/2020): Added
  • No changes since FY2021.

Common questions about D72.111

Is D72.111 billable?

Yes. D72.111 is a billable/specific ICD-10-CM code valid for FY2027 (October 1, 2026 – September 30, 2027).

Can D72.111 be used as a principal diagnosis?

Yes. The Medicare Code Editor doesn't restrict D72.111 as a principal diagnosis.

Is D72.111 a CC or MCC?

No. D72.111 is neither a CC nor an MCC under MS-DRG v44.0.

What DRG does D72.111 group to?

D72.111 is used in the MS-DRG v44.0 logic for MS-DRG 814 (Reticuloendothelial and Immunity Disorders with MCC), MS-DRG 815 (Reticuloendothelial and Immunity Disorders with CC) and MS-DRG 816 (Reticuloendothelial and Immunity Disorders without CC/MCC). Which one applies depends on whether it is the principal diagnosis and on the rest of the claim.